Susan Muffley Act of 2025

Senate Bill

S. 1950

119th Congress

Susan Muffley Act of 2025

In Committee

Introduced:Jul 9, 2025

Primary Sponsor

Jon Husted

Senator

Republican

OH

Cosponsors

8

Quick Stats

Policy Area

Crime and Law Enforcement

Summary

This bill aims to address the ongoing opioid crisis by requiring the Drug Enforcement Administration to quickly schedule, reschedule, or remove from scheduling certain fentanyl-related substances. It also makes it easier for researchers to study these controlled substances.

Latest Action

Read twice and referred to the Committee on the Judiciary.

SponsorJon Husted (R-OH)

Introduced7/9/2025

StatusRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Susan Muffley Act of 2025

This bill aims to address the ongoing opioid crisis by requiring the Drug Enforcement Administration to quickly schedule, reschedule, or remove from scheduling certain fentanyl-related substances. It also makes it easier for researchers to study these controll

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to address the ongoing opioid crisis by requiring the Drug Enforcement Administration to quickly schedule, reschedule, or remove from scheduling certain fentanyl-related substances. It also makes it easier for researchers to study these controlled substances.

Bill Number: 1950
Sponsor: Jon Husted (R-OH)
Introduced: 7/9/2025
Status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy Area: Crime and Law Enforcement

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Susan Muffley Act of 2025
Bill Number: 1950
Sponsor: Jon Husted (R-OH)
Status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced: 7/9/2025
Summary: This bill aims to address the ongoing opioid crisis by requiring the Drug Enforcement Administration to quickly schedule, reschedule, or remove from scheduling certain fentanyl-related substances. It also makes it easier for researchers to study these controlled substances.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to address the ongoing opioid crisis by requiring the Drug Enforcement Administration to quickly schedule, reschedule, or remove from scheduling certain fentanyl-related substances. It also makes it easier for researchers to study these controlled substances.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2023 or the TEST Act This bill provides for the rescheduling or removal from scheduling of certain fentanyl-related substances under the Controlled Substances Act.Specifically, the bill requires the Drug Enforcement Administration (DEA) to schedule, reschedule, or remove from scheduling fentanyl-related substances it has identified but not yet permanently scheduled within one year of the bill's enactment. The DEA must schedule, reschedule, or remove from scheduling any new fentanyl-related substances that it identifies after the bill's enactment within three years of identification. The DEA may temporarily schedule newly identified fentanyl-related substances under schedule I for up to three years.  The bill provides for the rescheduling of fentanyl-related substances to lower schedules, or for their removal from scheduling altogether, based on appropriate scientific and medical evaluations from the Department of Health and Human Services. The bill also provides for expedited registrations to research schedule I controlled substances, including by allowing for the continuation and consolidation of research under a single registration.

Key Points

Main provisions of the bill

Requires the DEA to take action on identifying and scheduling fentanyl-related substances within set time frames
Allows the DEA to temporarily schedule new fentanyl-related substances under the most restrictive schedule for up to 3 years
Provides for the rescheduling of fentanyl-related substances to lower schedules or removal from scheduling based on scientific and medical evaluations
Expedites the registration process for researchers to study schedule I controlled substances

How This Impacts Americans

Potential effects on citizens and communities

If passed, this bill would impact law enforcement, public health officials, and researchers working to address the opioid epidemic. It could lead to faster identification and regulation of dangerous fentanyl-related substances, while also making it easier for scientists to study these drugs and develop potential treatments or interventions.

Policy Areas

Primary Policy Area

Crime and Law Enforcement

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

1950, 119th Congress (2025). "Susan Muffley Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-1950

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Crime and Law Enforcement

HR 2978

GUARD Act

Referred to the Committee on the Judiciary, and in addition to the Committee on Financial Services,

HR 909

Crime Victims Fund Stabilization Act of 2025

Motion to place bill on Consensus Calendar filed by Mrs. Wagner.

S 1466

Resources for Victims of Gun Violence Act of 2025

Read twice and referred to the Committee on the Judiciary.

HR 2796

Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2025

Referred to the Committee on the Judiciary, and in addition to the Committees on Foreign Affairs, an